HUP0203225A3 - Benzodiazepin derivatives, the production and use thereof - Google Patents

Benzodiazepin derivatives, the production and use thereof

Info

Publication number: HUP0203225A3
Authority: HU; Hungary
Prior art keywords: production; benzodiazepin; derivatives; benzodiazepin derivatives
Prior art date: 1999-09-28

Application number

HU0203225A

Other languages

English (en)

Original Assignee

Basf Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-28

Filing date

2000-09-15

Publication date

2003-05-28

2000-09-15 Application filed by Basf Ag filed Critical Basf Ag

2003-01-28 Publication of HUP0203225A2 publication Critical patent/HUP0203225A2/hu

2003-05-28 Publication of HUP0203225A3 publication Critical patent/HUP0203225A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Diabetes (AREA)
Cardiology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Oncology (AREA)
Rheumatology (AREA)
Psychiatry (AREA)
Communicable Diseases (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Surgery (AREA)
Hematology (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pulmonology (AREA)

HU0203225A 1999-09-28 2000-09-15 Benzodiazepin derivatives, the production and use thereof HUP0203225A3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19946289A DE19946289A1 (de)	1999-09-28	1999-09-28	Benzodiazepin-Derivate, deren Herstellung und Anwendung
PCT/EP2000/009023 WO2001023386A2 (de)	1999-09-28	2000-09-15	Benzodiazepin-derivate, deren herstellung und anwendung

Publications (2)

Publication Number	Publication Date
HUP0203225A2 HUP0203225A2 (hu)	2003-01-28
HUP0203225A3 true HUP0203225A3 (en)	2003-05-28

Family

ID=7923476

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0203225A HUP0203225A3 (en)	1999-09-28	2000-09-15	Benzodiazepin derivatives, the production and use thereof

Country Status (21)

Country	Link
EP (1)	EP1222191B1 (hu)
JP (1)	JP2003510324A (hu)
KR (1)	KR20020031602A (hu)
CN (1)	CN1376156A (hu)
AR (1)	AR025721A1 (hu)
AT (1)	ATE310003T1 (hu)
AU (1)	AU7656700A (hu)
BG (1)	BG106444A (hu)
BR (1)	BR0014326A (hu)
CA (1)	CA2384265A1 (hu)
DE (2)	DE19946289A1 (hu)
ES (1)	ES2251405T3 (hu)
HK (1)	HK1048994A1 (hu)
HU (1)	HUP0203225A3 (hu)
IL (1)	IL148419A0 (hu)
NO (1)	NO20021379L (hu)
PL (1)	PL354118A1 (hu)
SK (1)	SK3802002A3 (hu)
TR (1)	TR200200820T2 (hu)
WO (1)	WO2001023386A2 (hu)
ZA (2)	ZA200104196B (hu)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HRP20010573B1 (en)	1999-01-11	2006-04-30	Agouron Pharmaceuticals	Tricyclic inhibitors of poly(adp-ribose) polymerases
WO2003103666A2 (en) *	2002-06-07	2003-12-18	Altana Pharma Ag	Novel 4,5-dihydro-imidazo[4,5,1-ij]quinolin-6-ones
US7786344B2 (en)	2002-07-26	2010-08-31	Basf Plant Science Gmbh	Selection method
US7223759B2 (en)	2003-09-15	2007-05-29	Anadys Pharmaceuticals, Inc.	Antibacterial 3,5-diaminopiperidine-substituted aromatic and heteroaromatic compounds
US7772271B2 (en)	2004-07-14	2010-08-10	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
US7781478B2 (en)	2004-07-14	2010-08-24	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
US7868037B2 (en)	2004-07-14	2011-01-11	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
JP2008507518A (ja)	2004-07-22	2008-03-13	ピーティーシーセラピューティクス，インコーポレーテッド	Ｃ型肝炎を治療するためのチエノピリジン
AU2006222012B2 (en)	2005-03-08	2011-03-31	Basf Plant Science Gmbh	Expression enhancing intron sequences
WO2006101937A1 (en)	2005-03-18	2006-09-28	Janssen Pharmaceutica N.V.	Acylhydrazones as kinase modulators
WO2011064750A1 (en)	2009-11-27	2011-06-03	Basf Plant Science Company Gmbh	Chimeric endonucleases and uses thereof
AU2010325564A1 (en)	2009-11-27	2012-07-12	Basf Plant Science Company Gmbh	Chimeric endonucleases and uses thereof
BR112012012588B1 (pt)	2009-11-27	2019-03-26	Basf Plant Science Company Gmbh	Endonuclease, método para recombinação homóloga de polinucleotídeos e método para mutação direcionada de polinucleotídeos
WO2012088266A2 (en)	2010-12-22	2012-06-28	Incyte Corporation	Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
NZ702747A (en)	2012-06-13	2017-03-31	Incyte Holdings Corp	Substituted tricyclic compounds as fgfr inhibitors
WO2014026125A1 (en)	2012-08-10	2014-02-13	Incyte Corporation	Pyrazine derivatives as fgfr inhibitors
CN104754942A (zh) *	2012-09-05	2015-07-01	拜尔农作物科学股份公司	取代的苯并二氮杂卓酮和苯并氮杂卓酮或它们的盐作为对抗植物非生物胁迫的活性物质的用途
US9266892B2 (en)	2012-12-19	2016-02-23	Incyte Holdings Corporation	Fused pyrazoles as FGFR inhibitors
LT2986610T (lt)	2013-04-19	2018-04-10	Incyte Holdings Corporation	Bicikliniai heterociklai, kaip fgfr inhibitoriai
JP6579549B2 (ja)	2014-05-16	2019-09-25	塩野義製薬株式会社	Ｈｉｖ複製阻害作用を有する３環性複素環誘導体
US10851105B2 (en)	2014-10-22	2020-12-01	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
US9580423B2 (en)	2015-02-20	2017-02-28	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
SG10201913036RA (en)	2015-02-20	2020-02-27	Incyte Corp	Bicyclic heterocycles as fgfr inhibitors
MA41551A (fr)	2015-02-20	2017-12-26	Incyte Corp	Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
MX2017015256A (es)	2015-05-29	2018-02-19	Shionogi & Co	Derivados triciclicos que contienen nitrogeno que tienen actividad inhibidora de la replicacion del virus de inmunodeficiencia adquirida (vih).
CN105153195B (zh) *	2015-09-01	2017-09-26	汤文建	一种三环吡唑[1,5‑d][1,4]苯并氧氮杂卓酮衍生物及其制备方法与用途
AR111960A1 (es)	2017-05-26	2019-09-04	Incyte Corp	Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
EP4309737A3 (en)	2018-05-04	2024-03-27	Incyte Corporation	Solid forms of an fgfr inhibitor and processes for preparing the same
EP3788046B1 (en)	2018-05-04	2025-12-10	Incyte Corporation	Salts of an fgfr inhibitor
US11034669B2 (en)	2018-11-30	2021-06-15	Nuvation Bio Inc.	Pyrrole and pyrazole compounds and methods of use thereof
US11628162B2 (en)	2019-03-08	2023-04-18	Incyte Corporation	Methods of treating cancer with an FGFR inhibitor
US11591329B2 (en)	2019-07-09	2023-02-28	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
WO2021067374A1 (en)	2019-10-01	2021-04-08	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
CR20220169A (es)	2019-10-14	2022-10-27	Incyte Corp	Heterociclos bicíclicos como inhibidores de fgfr
WO2021076728A1 (en)	2019-10-16	2021-04-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
CA3163875A1 (en)	2019-12-04	2021-06-10	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
KR20220131900A (ko)	2019-12-04	2022-09-29	인사이트 코포레이션	Fgfr 억제제의 유도체
US12012409B2 (en)	2020-01-15	2024-06-18	Incyte Corporation	Bicyclic heterocycles as FGFR inhibitors
US12065494B2 (en)	2021-04-12	2024-08-20	Incyte Corporation	Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent
AR126102A1 (es)	2021-06-09	2023-09-13	Incyte Corp	Heterociclos tricíclicos como inhibidores de fgfr
AR126101A1 (es)	2021-06-09	2023-09-13	Incyte Corp	Heterociclos tricíclicos como inhibidores de fgfr

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL93136A (en) *	1989-02-23	1995-01-24	Janssen Pharmaceutica Nv	Tetrahydroimidazo (1,4) benzodiazepin-2-thione derivatives, their preparation and pharmaceutical compositions containing them
TR199800127T1 (xx) *	1995-08-02	1998-04-21	Newcastle University Ventures Limited	Benzimidazol bile�ikleri.
ECSP003637A (es) *	1999-08-31	2002-03-25	Agouron Pharma	Inhibidores triciclicos de poli (adp-ribosa) polimerasas

1999
- 1999-09-28 DE DE19946289A patent/DE19946289A1/de not_active Withdrawn
2000
- 2000-09-15 AT AT00966022T patent/ATE310003T1/de not_active IP Right Cessation
- 2000-09-15 CN CN00813443A patent/CN1376156A/zh active Pending
- 2000-09-15 IL IL14841900A patent/IL148419A0/xx unknown
- 2000-09-15 PL PL00354118A patent/PL354118A1/xx not_active Application Discontinuation
- 2000-09-15 HU HU0203225A patent/HUP0203225A3/hu unknown
- 2000-09-15 HK HK03101161.8A patent/HK1048994A1/zh unknown
- 2000-09-15 KR KR1020027003975A patent/KR20020031602A/ko not_active Ceased
- 2000-09-15 TR TR2002/00820T patent/TR200200820T2/xx unknown
- 2000-09-15 EP EP00966022A patent/EP1222191B1/de not_active Expired - Lifetime
- 2000-09-15 DE DE50011656T patent/DE50011656D1/de not_active Expired - Lifetime
- 2000-09-15 SK SK380-2002A patent/SK3802002A3/sk unknown
- 2000-09-15 JP JP2001526538A patent/JP2003510324A/ja not_active Ceased
- 2000-09-15 AU AU76567/00A patent/AU7656700A/en not_active Abandoned
- 2000-09-15 BR BR0014326-0A patent/BR0014326A/pt not_active IP Right Cessation
- 2000-09-15 CA CA002384265A patent/CA2384265A1/en not_active Abandoned
- 2000-09-15 ES ES00966022T patent/ES2251405T3/es not_active Expired - Lifetime
- 2000-09-15 WO PCT/EP2000/009023 patent/WO2001023386A2/de not_active Ceased
- 2000-09-20 AR ARP000104924A patent/AR025721A1/es unknown
2001
- 2001-05-23 ZA ZA200104196A patent/ZA200104196B/xx unknown
2002
- 2002-02-22 ZA ZA200201494A patent/ZA200201494B/xx unknown
- 2002-02-26 BG BG06444A patent/BG106444A/xx unknown
- 2002-03-20 NO NO20021379A patent/NO20021379L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
ATE310003T1 (de)	2005-12-15
WO2001023386A2 (de)	2001-04-05
ZA200104196B (en)	2002-07-25
HUP0203225A2 (hu)	2003-01-28
HK1048994A1 (zh)	2003-04-25
WO2001023386A3 (de)	2002-05-10
NO20021379D0 (no)	2002-03-20
KR20020031602A (ko)	2002-05-02
NO20021379L (no)	2002-03-20
EP1222191A2 (de)	2002-07-17
TR200200820T2 (tr)	2002-09-23
AR025721A1 (es)	2002-12-11
ES2251405T3 (es)	2006-05-01
BR0014326A (pt)	2002-05-28
ZA200201494B (en)	2003-12-31
JP2003510324A (ja)	2003-03-18
SK3802002A3 (en)	2003-03-04
PL354118A1 (en)	2003-12-29
BG106444A (en)	2002-09-30
DE50011656D1 (de)	2005-12-22
DE19946289A1 (de)	2001-03-29
IL148419A0 (en)	2002-09-12
CN1376156A (zh)	2002-10-23
AU7656700A (en)	2001-04-30
CA2384265A1 (en)	2001-04-05
EP1222191B1 (de)	2005-11-16

Publication	Publication Date	Title
HUP0203225A3 (en)	2003-05-28	Benzodiazepin derivatives, the production and use thereof
IL143349A0 (en)	2002-04-21	Azepinoindole derivatives, the production and use thereof
ZA200203316B (en)	2004-02-25	New use and novel n-azabicyclo-amide derivatives.
IL148545A0 (en)	2002-09-12	Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
PL347500A1 (en)	2002-04-08	Substituted 2-phenylbenzimidazoles, the production thereof and their use
AU7563800A (en)	2001-04-30	Marsh-mallow and the marsh-mallow production technique
PL344467A1 (en)	2001-11-05	Substituted indolinones, the production thereof and their use as medicaments
PL347072A1 (en)	2002-03-11	Indeno-, naphto- and benzocyclohepta dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
IL140060A0 (en)	2002-02-10	Benzimidazoles, production thereof and use thereof as medicaments
HUP0203290A3 (en)	2004-12-28	Indeno-, naphto-, and benzocyclohepta-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
IL135451A0 (en)	2001-05-20	3-amino-3-arylpropan-1-ol derivatives, their preparation and use
MXPA03000644A (es)	2003-06-06	Nuevos derivados de indol y uso como medicamentos.
IL136950A0 (en)	2001-06-14	Heterocyclic compounds, their production and use
GB0023323D0 (en)	2000-11-08	Arylhydantoin derivatives and uses thereof
FI104003B1 (fi)	1999-10-29	Stabiloitu täyteaine, sen valmistus ja käyttö
HUP0600238A3 (en)	2009-12-28	Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
HU0001397D0 (en)	2000-06-28	3-amino-3-arylpropan-1-ol derivatives, production and use thereof
HUP0103358A3 (en)	2002-10-28	N-substituted azabicycloheptane derivatives, production and use thereof
IL157793A0 (en)	2004-03-28	Caloporoside derivatives, methods for the production thereof and their use
HUP0203455A3 (en)	2003-12-29	2-arylquinoline derivatives, preparation and therautic use thereof
SI1230230T1 (en)	2004-02-29	Indeno-dihydrothiazole derivatives, the production thereof and their use as anorectic medicaments
SI1127052T1 (en)	2005-06-30	Substituted 2-phenylbenzimidazoles, the production thereof and their use
SI1372670T1 (en)	2005-10-31	Caloporoside derivatives, methods for the production thereof and their use
HUP0103099A3 (en)	2002-12-28	N-substituted azabicycloheptane derivatives, production and use thereof
SI1105388T1 (en)	2003-10-31	N-substituted azabicycloheptane derivatives, production and use thereof